您当前的位置:首页 > 核医学

介入治疗肺结核大咯血的疗效观察

时间:2005-08-23 19:20:17  来源:  作者:

Observation of Clinical Effectiveness Via Interventional Treatment of Massive Hemoptysis Caused by Pulmonary Tuberculosis <?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />

 

陆普选* 朱文科* 蔡雄茂# 曹满瑞

余卫业# 杨根东* 孙燕芝# 刘锦清*

LU Puxuan,ZHU Weike CAI xiongmao, et al. Department of Radiology, Shenzhen East Lake hospital ,Shenzhen, China 518020,

 

Abstract

Objective:To investigate the effect of bronchial artery infusion with Reptilase plus with or not target artery embolization in treatment of massive hemoptysis caused by pulmonary tuberculosis.

Methods:Among 34 patients with massive hemoptysis (≥600ml/24Hours) caused by pulmonary tuberculosis, 21 cases (group 1) were treated by bronchial artery infusion with Reptilase (1—3KU) plus target artery embolization with gelfoam sponge.13 cases (group 2) were treated only by bronchial artery infusion with Reptilase (1—3KU) due to inaccessible to the bleed target artery.

Results:32 of 34 cases (94.1%) in total were cured by this therapy, 2 cases (one in each group) needed further surgery treatment . Among the cured 34 cases, 32 cases received treatment for one time,1 cases 2 times and 1 case 3 times. There is no significant difference between the efficacy of treatment of group 1 and group 2 (P>0.05).

Conclusion:Bronchial artery infusion with Reptilase plus with or not target artery embolization is effective and safe method in therapy of massive hemoptysis caused by pulmonary tuberculosis. In case of inaccessible to target the bleed artery in lung, infusion with Reptilase (1—3KU) locally is an optional and useful to treat the hemoptysis.

Key words:Reptilase; bronchial artery; intervention/therapy; massive hemoptysis/pulmonary tuberculosis 

 

介入放射学的开展,为肺结核大咯血的治疗开辟了有效的新途径,取得较为满意的效果[1.2.3]。由于支气管动脉的解剖变异较大,支气管动脉与肋间动脉和/或脊髓动脉共干者约占60℅[4]。因此,支气管动脉栓塞治疗肺结核大咯血,有时技术上受到一定限制,治疗效果受到影响。为提高肺结核大咯血治疗的有效率,我们对34例肺结核大咯血病人进行支气管动脉内应用立止血治疗,取得满意的疗效,现报告如下。

来顶一下
返回首页
返回首页
 
推荐资讯
掌间筑未来,西门子医疗推出全新CT产品SOMATOM go.
掌间筑未来,西门子医疗
“智”动创新 共享“健康中国” 西门子医疗亮相2017 HOSPEQ
“智”动创新 共享“
西门子医疗携一系列创新成果亮相CMEF 2017   助力“智慧”医疗服务建设
西门子医疗携一系列创
西门子医疗中国亮相第77届中国国际医疗器械春季博览会,多方位展示互联网时代下 “智慧”成果
西门子医疗中国亮相第
最后更新
热门点击
  1. 21世纪核医学需要什么样的技术人员?
  2. 渗透压对对比剂肾病发生率的影响:有关在高
  3. 核医学技师出路在何方?对核医学技术人员队伍
  4. PET-CT在肾上腺肿瘤诊断中的诊断效能和判读
  5. 核医学:传统经典的新兴学科
  6. 冠状动脉造影、心电图、核素检查对冠心病诊
  7. 核医学检查对人体有伤害吗?
  8. 《走进核医学》教学录相片的制作
  9. 高分辨率 MRI 可确诊大脑前动脉夹层
  10. 内皮抑素基因联合放射治疗对大鼠Walker-256